glp-1 news 2025 november 25 trends 2025: real-world data, patient outcomes & future therapies Consumers' Expectations about GLP-1 Drugs

Eli Lillys first nine months of 2025 underscored the scale of the GLP-1 surge: Mounjaro and Zepbound generated $39.5 billion in revenue and surpasses Mercks Keytruda as the worlds best-selling medicine[5]

Understand dose strength vs volume for safe diabetes management.

FDA approves Foundayo (orforglipron) the first GLP-1 pill with no food restrictions

GLP-1 receptor agonist injections require proper subcutaneous placement in specific body areas to ensure consistent absorption and minimize discomfort

If you're breastfeeding, you're probably wondering: is it safe

Despite decades of research, treatment options are sparse or missing, and relapse rates are high